DICE Therapeutics Inc.

47.55
0.03 (0.06%)
At close: Aug 08, 2023, 8:00 PM

DICE Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
-34.82M -25.65M -23.22M -20.55M -21.52M -18.59M -16.2M -17.34M -7.36M -8.07M -7.13M -6.02M
687K 630K 609K 595K 700K 519K 156K 146K 179K 180K 172K 169K
5.5M 4.89M 3.34M 3.46M 4.21M 1.81M 1.68M 3.16M 396K 347K 150K 149K
2.87M -472K -529K 142K 1.51M -1.31M 1.92M 1.65M -991K -157K 105K 409K
-2.7M -2.37M 288K 98K 930K 29K 164K 1.4M 219K -8K 52K 38K
n/a n/a n/a n/a n/a 329K 135K 1.38M n/a n/a n/a n/a
2.75M 60K 1.09M 1.07M -1.26M 1.74M -217K 3.7M -1.39M -451K 1.18M 549K
-28.58M -22.44M -17.89M -15.32M -16.94M -14.16M -14.41M -8.92M -7.96M -8M -5.58M -5.11M
-1.83M -202K -437K -524K -891K -385K -196K -121K -36K -365K -17K n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-53.96M -397.72M -44.61M -29.14M -44.61M -65.51M -191.5M -15K -2.87M -24.08M n/a -1K
55M 60.27M 106.42M 76.5M 28.06M 18M 11.87M 2.7M n/a n/a n/a 3M
n/a n/a 44.61M n/a n/a n/a n/a n/a n/a n/a n/a n/a
-792K -337.65M 105.98M 46.84M -17.44M -47.89M -179.83M 2.56M -2.91M -24.45M -17K 3M
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
4.83B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
-4.83B 292K 325.04M -8K -2.67M -108K -1.54M 302.46M 1.85M -2.52M 54.32M -361K
1.24M 292K 325.04M -8K -2.67M -108K -1.54M 302.46M 1.85M -2.52M 54.32M -361K
-28.13M -359.8M 413.12M 31.5M -37.05M -62.16M -195.78M 296.11M -9.02M -34.97M 48.72M -2.47M
-30.41M -22.64M -18.33M -15.85M -17.83M -14.55M -14.61M -9.04M -7.99M -8.36M -5.59M -5.11M